Development of Celiac Disease Therapeutics: Report of the Third Gastroenterology Regulatory Endpoints and Advancement of Therapeutics Workshop

被引：21

作者：

Leffler, Daniel ^{[1
]}

Kupfer, Sonia S. ^{[2
]}

Lebwohl, Benjamin ^{[3
]}

Bugin, Kevin ^{[4
]}

Griebel, Donna ^{[4
]}

Lathrop, Julia Tait ^{[4
]}

Lee, Jessica J. ^{[4
]}

Mulberg, Andrew E. ^{[4
]}

Papadopoulos, Elektra ^{[4
]}

Tomaino, Juli ^{[4
]}

Crowe, Sheila E. ^{[5
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA

[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA

[3] Columbia Univ, Dept Med, New York, NY USA

[4] US FDA, Silver Spring, MD USA

[5] Univ Calif San Diego, Dept Med, 9500 Gilman Dr,BRF 2,Off 4A30, La Jolla, CA 92093 USA

来源：

GASTROENTEROLOGY | 2016年 / 151卷 / 03期

关键词：

GLUTEN-FREE DIET; PREDICTORS; ANTIBODIES; DIAGNOSIS; MORTALITY; SYMPTOMS; ADULTS;

D O I：

10.1053/j.gastro.2016.07.025

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：407 / 411

页数：5

共 50 条

[41] REGULATORY PERSPECTIVES FOR EARLY PHASE DEVELOPMENT OF PROTEIN AND PEPTIDE BIO-THERAPEUTICS
Bell, R.
BIOPOLYMERS, 2009, 92 (04) : 299 - 299
[42] Workshop on the Development and Evaluation of Digital Therapeutics for Health Behavior Change: Science, Methods, and Projects
Budney, Alan J.
Marsch, Lisa A.
Aklin, Will M.
Borodovsky, Jacob T.
Brunette, Mary F.
Campbell, Andrew T.
Dallery, Jesse
Kotz, David
Knapp, Ashley A.
Lord, Sarah E.
Nunes, Edward, V
Scherer, Emily A.
Stanger, Catherine
Torrey, William C.
JMIR MENTAL HEALTH, 2020, 7 (02):
[43] Development of Hydrogen Sulfide-Based Therapeutics for Cardiovascular Disease
Predmore, Benjamin L.
Lefer, David J.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2010, 3 (05) : 487 - 498
[44] DEVELOPMENT OF SMALL MOLECULE EPIGENETIC THERAPEUTICS FOR INFLAMMATORY BOWEL DISEASE
Li, Yi
Uribe, Gabriela
Wang Pingyuan
Chen, Haiying
Liu, Zhiqing
Cong, Yingzi
Brasier, Allan
Pinchuk, Irina
Tian, Bing
Zhou, Jia
GASTROENTEROLOGY, 2021, 160 (03) : S48 - S48
[45] Novel Complement Therapeutics in Development as Potential Treatment for Renal Disease
Kelleher, Catherine
Kocinsky, Hetal
ADVANCES IN CHRONIC KIDNEY DISEASE, 2020, 27 (02) : 95 - 103
[46] Development of Hydrogen Sulfide-Based Therapeutics for Cardiovascular Disease
Benjamin L. Predmore
David J. Lefer
Journal of Cardiovascular Translational Research, 2010, 3 : 487 - 498
[47] Advances in the Development of Kinase Inhibitor Therapeutics for Alzheimer's Disease
Savage, Mary J.
Gingrich, Diane E.
DRUG DEVELOPMENT RESEARCH, 2009, 70 (02) : 125 - 144
[48] Development of novel peptidic therapeutics for the treatment of sickle cell disease
Wynn, Cody G.
Brennan, Brian B.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[49] Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease
Huang, Cheng-Kai
Kafert-Kasting, Sabine
Thum, Thomas
CIRCULATION RESEARCH, 2020, 126 (05) : 663 - 678
[50] DEVELOPMENT OF SMALL MOLECULE EPIGENETIC THERAPEUTICS FOR INFLAMMATORY BOWEL DISEASE
Li, Yi
Uribe, Gabriela
Wang Pingyuan
Chen, Haiying
Liu, Zhiqing
Cong, Yingzi
Brasier, Allan
Pinchuk, Irina
Tian, Bing
Zhou, Jia
INFLAMMATORY BOWEL DISEASES, 2021, 27 : S35 - S36

← 1 2 3 4 5 →